Masimo (NASDAQ:MASI) Lowered to "Hold" Rating by Wall Street Zen

Key Points

• Masimo has been downgraded from a "buy" rating to a "hold" rating by analysts at Wall Street Zen, amid mixed reviews from other research firms.
• The company reported an earnings per share (EPS) of $1.33 for the last quarter, exceeding analyst expectations, with a year-over-year revenue increase of 7.7%.
• Institutional investors now hold 85.96% of Masimo's stock, indicating strong institutional interest in the company.

Masimo (NASDAQ:MASI - Get Free Report) was downgraded by analysts at Wall Street Zen from a "buy" rating to a "hold" rating in a report issued on Monday.

A number of other research firms have also commented on MASI. Weiss Ratings reissued a "sell (d)" rating on shares of Masimo in a research note on Saturday, September 27th. Piper Sandler boosted their target price on Masimo from $200.00 to $210.00 and gave the stock an "overweight" rating in a research report on Wednesday, August 6th. Zacks Research upgraded Masimo from a "hold" rating to a "strong-buy" rating in a research report on Wednesday, September 3rd. Finally, BTIG Research restated a "buy" rating and set a $198.00 target price on shares of Masimo in a research report on Thursday, September 11th. One analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, Masimo currently has a consensus rating of "Moderate Buy" and a consensus target price of $194.60.

Masimo Price Performance

Masimo stock opened at $147.29 on Monday. The company has a debt-to-equity ratio of 0.57, a quick ratio of 1.61 and a current ratio of 2.14. The firm has a market cap of $8.00 billion, a P/E ratio of -17.29 and a beta of 1.28. The business's fifty day moving average is $146.78 and its two-hundred day moving average is $155.79. Masimo has a 52 week low of $132.67 and a 52 week high of $194.88.

Masimo (NASDAQ:MASI - Get Free Report) last posted its quarterly earnings data on Tuesday, August 5th. The medical equipment provider reported $1.33 EPS for the quarter, topping analysts' consensus estimates of $1.22 by $0.11. The company had revenue of $370.90 million for the quarter, compared to analyst estimates of $368.65 million. Masimo had a positive return on equity of 26.54% and a negative net margin of 24.85%.The business's revenue was up 7.7% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.86 earnings per share. Equities research analysts forecast that Masimo will post 4.1 earnings per share for the current fiscal year.

Insider Activity

In other Masimo news, Director William R. Jellison purchased 3,000 shares of the stock in a transaction on Monday, August 11th. The stock was bought at an average cost of $145.98 per share, for a total transaction of $437,940.00. Following the completion of the acquisition, the director directly owned 4,790 shares of the company's stock, valued at $699,244.20. The trade was a 167.60% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 9.70% of the stock is owned by company insiders.

Institutional Investors Weigh In On Masimo

Several large investors have recently modified their holdings of MASI. Twin Tree Management LP bought a new stake in shares of Masimo in the first quarter worth about $29,000. MAI Capital Management boosted its position in shares of Masimo by 176.7% during the second quarter. MAI Capital Management now owns 202 shares of the medical equipment provider's stock worth $34,000 after buying an additional 129 shares during the period. Farther Finance Advisors LLC boosted its position in shares of Masimo by 128.9% during the first quarter. Farther Finance Advisors LLC now owns 206 shares of the medical equipment provider's stock worth $35,000 after buying an additional 116 shares during the period. Hilltop National Bank acquired a new position in shares of Masimo during the second quarter worth about $37,000. Finally, Anderson Financial Strategies LLC acquired a new position in shares of Masimo during the first quarter worth about $49,000. 85.96% of the stock is currently owned by institutional investors.

Masimo Company Profile

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.